Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

DeSoto, Texas

CNS medication trials in DeSoto, TX

23 CNS medication studies are recruiting participants at sites in DeSoto as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

DeSoto at a glance

  • 23 studies are recruiting at a site in DeSoto.
  • By phase: Phase 1 (1), Phase 2 (6), Phase 3 (15), Phase 4 (1).
  • By sponsor: industry (23).
  • By research area: Depression (9), Schizophrenia (9), Bipolar Disorder (3), Migraine (2).
  • Most recent update to one of these records: November 13, 2026.

Depression studies recruiting in DeSoto

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 85
    • All sexes
    Sponsor
    Cybin IRL Limited
    Study site
    Adams Clinical Dallas
    Registry record
    NCT06793397 · updated
  2. A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Adams Clinical Dallas
    Registry record
    NCT07412756 · updated
  3. A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Adams Clinical Dallas
    Registry record
    NCT07775300 · updated
  4. Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06966401 · updated
  5. A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Draig Therapeutics Ltd
    Study site
    Draig Clinical Site
    Registry record
    NCT07610473 · updated
  6. A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Draig Therapeutics Ltd
    Study site
    Draig Clinical Site
    Registry record
    NCT07300969 · updated
  7. NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06911112 · updated
  8. Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Syndeio Biosciences, Inc
    Study site
    InSite Clinical Research, LLC
    Registry record
    NCT06547489 · updated
  9. Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    LB Pharmaceuticals Inc.
    Study site
    Adams Clinical
    Registry record
    NCT07494305 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in DeSoto, TX on ClinicalTrials.gov.

Schizophrenia studies recruiting in DeSoto

  1. A Study to Evaluate the Effect of KarXT on Urological Safety

    • Phase 4
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Adams Clinical Dallas
    Registry record
    NCT07221877 · updated
  2. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Epic Medical Research LLC - DeSoto
    Registry record
    NCT06585787 · updated
  3. A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT07459647 · updated
  4. A Study of Brenipatide in Adult Participants With Schizophrenia

    • Phase 2
    • Ages 18 to 55
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Adams Clinical Dallas
    Registry record
    NCT07410507 · updated
  5. NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07114874 · updated
  6. Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07227818 · updated
  7. 52-week Open Label Safety-Tolerability Study

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    LB Pharmaceuticals Inc.
    Study site
    Adams Clinical
    Registry record
    NCT07369154 · updated
  8. Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

    • Phase 1
    • Ages 10 to 17
    • All sexes
    Sponsor
    BioXcel Therapeutics Inc
    Study site
    BioXcel Clinical Research Site
    Registry record
    NCT05025605 · updated
  9. NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06963034 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in DeSoto, TX on ClinicalTrials.gov.

Bipolar disorder studies recruiting in DeSoto

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Adams Clinical Dallas
    Registry record
    NCT06951711 · updated
  2. A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Adams Clinical Dallas
    Registry record
    NCT07140913 · updated
  3. A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Adams Clinical Dallas
    Registry record
    NCT06929273 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in DeSoto, TX on ClinicalTrials.gov.

Migraine studies recruiting in DeSoto

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Epic Medical Research - DeSoto
    Registry record
    NCT07816367 · updated
  2. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Epic Medical Research - DeSoto /ID# 274314
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in DeSoto, TX on ClinicalTrials.gov.

Ask about studies near DeSoto

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Texas

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call